Ngā hua rapu - Hiroyoshi Nishikawa

Whakamahine hua
  1. 1
    In vivo antigen delivery by aSalmonella typhimurium type III secretion system for therapeutic cancer vaccines

    In vivo antigen delivery by aSalmonella typhimurium type III secretion system for therapeutic cancer vaccines mā Hiroyoshi Nishikawa

    I whakaputaina 2006
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Regulatory T cells in tumor immunity

    Regulatory T cells in tumor immunity mā Hiroyoshi Nishikawa, Shimon Sakaguchi

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Roles of regulatory T cells in cancer immunity

    Roles of regulatory T cells in cancer immunity mā Yoshiko Takeuchi, Hiroyoshi Nishikawa

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Regulatory T cells: a potential target in cancer immunotherapy

    Regulatory T cells: a potential target in cancer immunotherapy mā Kohei Shitara, Hiroyoshi Nishikawa

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?

    Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? mā Yoshihiro Ohue, Hiroyoshi Nishikawa

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies

    Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies mā Shohei Koyama, Hiroyoshi Nishikawa

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Engineering strategies for broad application of TCR-T- and CAR-T-cell therapies

    Engineering strategies for broad application of TCR-T- and CAR-T-cell therapies mā Keisuke Watanabe, Hiroyoshi Nishikawa

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Natural and Induced T Regulatory Cells in Cancer

    Natural and Induced T Regulatory Cells in Cancer mā Dennis O. Adeegbe, Hiroyoshi Nishikawa

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Transcriptional regulatory network for the establishment of CD8+ T cell exhaustion

    Transcriptional regulatory network for the establishment of CD8+ T cell exhaustion mā Wooseok Seo, Chandsultana Jerin, Hiroyoshi Nishikawa

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Metabolic advantages of regulatory T cells dictated by cancer cells

    Metabolic advantages of regulatory T cells dictated by cancer cells mā Masaki Kondo, Shogo Kumagai, Hiroyoshi Nishikawa

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    A mixture-of-experts deep generative model for integrated analysis of single-cell multiomics data

    A mixture-of-experts deep generative model for integrated analysis of single-cell multiomics data mā Kodai Minoura, Ko Abe, Hyunha Nam, Hiroyoshi Nishikawa, Teppei Shimamura

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Reprogramming the Tumor Microenvironment to Improve Immunotherapy: Emerging Strategies and Combination Therapies

    Reprogramming the Tumor Microenvironment to Improve Immunotherapy: Emerging Strategies and Combination Therapies mā Meenal Datta, Lisa M. Coussens, Hiroyoshi Nishikawa, F. Stephen Hodi, Rakesh K. Jain

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal

    Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal mā Sho Isoyama, Shigeyuki Mori, Daisuke Sugiyama, Yasuhiro Kojima, Yasuko Tada, Kohei Shitara, Kunihiko Hinohara, Shingo Dan, Hiroyoshi Nishikawa

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer

    The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer mā Noriko Goda, Shinsuke Sasada, Hideo Shigematsu, Norio Masumoto, Koji Arihiro, Hiroyoshi Nishikawa, Shimon Sakaguchi, Morihito Okada, Takayuki Kadoya

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Regulatory T Cell–Resistant CD8+ T Cells Induced by Glucocorticoid-Induced Tumor Necrosis Factor Receptor Signaling

    Regulatory T Cell–Resistant CD8+ T Cells Induced by Glucocorticoid-Induced Tumor Necrosis Factor Receptor Signaling mā Hiroyoshi Nishikawa, Takuma Kato, Michiko Hirayama, Yuki Orito, Eiichi Sato, Naozumi Harada, Sacha Gnjatic, Lloyd J. Old, Hiroshi Shiku

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8+ T cells in the tumor microenvironment

    Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8+ T cells in the tumor microenvironment mā Yasuko Tada, Yosuke Togashi, Daisuke Kotani, Takeshi Kuwata, E Sato, Akihito Kawazoe, Toshihiko Doi, Hisashi Wada, Hiroyoshi Nishikawa, Kohei Shitara

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    IFN-γ Controls the Generation/Activation of CD4+CD25+ Regulatory T Cells in Antitumor Immune Response

    IFN-γ Controls the Generation/Activation of CD4+CD25+ Regulatory T Cells in Antitumor Immune Response mā Hiroyoshi Nishikawa, Takuma Kato, Isao Tawara, Hiroaki Ikeda, Kagemasa Kuribayashi, Paul M. Allen, Robert D. Schreiber, Lloyd J. Old, Hiroshi Shiku

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Selective inhibition of low-affinity memory CD8+ T cells by corticosteroids

    Selective inhibition of low-affinity memory CD8+ T cells by corticosteroids mā Akihiro Tokunaga, Daisuke Sugiyama, Yuka Maeda, Allison Betof Warner, Katherine S. Panageas, Sachiko Ito, Yosuke Togashi, Chika Sakai, Jedd D. Wolchok, Hiroyoshi Nishikawa

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages

    Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages mā Takahiko Sato, Daisuke Sugiyama, Jun Koseki, Yasuhiro Kojima, Satomi Hattori, Kazuki Sone, Hitomi Nishinakamura, Tomohiro Ishikawa, Yuichi Ishikawa, T. Kato, Hitoshi Kiyoi, Hiroyoshi Nishikawa

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein–Barr virus status, and cancer genome alterations in metastatic gastric cancer

    Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein–Barr virus status, and cancer genome alterations in metastatic gastric cancer mā Akihito Kawazoe, Kohei Shitara, Yasutoshi Kuboki, Hideaki Bando, Takashi Kojima, Takayuki Yoshino, Atsushi Ohtsu, Atsushi Ochiai, Yosuke Togashi, Hiroyoshi Nishikawa, Toshihiko Doi, Takeshi Kuwata

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: